Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DMRADamora Therapeutics, Inc.

Nasdaq · CIK 0001800315
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts231

Identity from submissions API

NameDamora Therapeutics, Inc.
CIK0001800315
TickersDMRA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN371957007
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(781) 281-9020
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Galecto, Inc. (2020-09-29T04:00:00.000Z → 2026-03-10T04:00:00.000Z)
  • Galecto Inc. (2020-01-16T05:00:00.000Z → 2020-10-28T04:00:00.000Z)
Business address
100 FIFTH AVENUE
SUITE 700
WALTHAM
MA
02451
MA
Mailing address
100 FIFTH AVENUE
SUITE 700
WALTHAM
MA
02451
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

353 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-04 10-Q 10-Q 0001193125-26-447162 001-39655 261521906 34 11677318 1 1
2026-09-28 4 4 0001193125-26-403355 5778
2026-08-13 4 4 0001193125-26-349537 5642
2026-08-13 3 3 0001193125-26-349515 12815
2026-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002630 333-292175 261269671 33 1976
2026-08-10 S-8 POS S-8 POS 0001193125-26-342737 333-294492 261259673 33 767133
2026-08-10 S-8 POS S-8 POS 0001193125-26-342730 333-292564 261259661 33 767133
2026-08-10 POSASR POSASR 0001193125-26-342717 333-293343 261259636 33 1078379
2026-08-10 S-8 POS S-8 POS 0001193125-26-342710 333-285920 261259613 33 767133
2026-08-10 S-8 POS S-8 POS 0001193125-26-342698 333-277792 261259582 33 767133
2026-08-10 S-8 POS S-8 POS 0001193125-26-342687 333-270380 261259566 33 767133
2026-08-10 S-8 POS S-8 POS 0001193125-26-342677 333-262823 261259544 33 767133
2026-08-10 S-8 POS S-8 POS 0001193125-26-342672 333-254805 261259528 33 767133
2026-08-10 S-8 POS S-8 POS 0001193125-26-342663 333-249852 261259502 33 767133
2026-08-10 POS AM POS AM 0001193125-26-342562 333-292175 261259163 33 100699
2026-08-10 8-A12B/A 8-A12B/A 0001193125-26-342406 001-39655 261258568 34 60960
2026-08-10 10-Q 10-Q 0001193125-26-342307 001-39655 261258248 34 12503000 1 1
2026-08-06 144 xsl144X01/primary_doc.xml 0001970051-26-000018 001-39655 261247605 33 6351
2026-07-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002507 005-91812 261212542 34 11109
2026-07-20 8-K 8-K 1.01,3.03,5.03,7.01,9.01 0001193125-26-308899 001-39655 261186637 34 1245713 1 1
2026-07-07 4 4 0001193125-26-297818 9123
2026-06-22 144 xsl144X01/primary_doc.xml 0001970051-26-000017 001-39655 261106192 33 5579
2026-06-17 8-K 8-K 5.07 0001193125-26-274093 001-39655 261098203 34 212502 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003477 005-91812 26988014 34 12547
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002524 005-91812 26987835 34 11836
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002463 005-91812 26982484 34 14943
2026-05-12 10-Q 10-Q 0001193125-26-219327 001-39655 26968260 34 9212626 1 1
2026-05-08 3 3 0001193125-26-214909 14397
2026-05-04 8-K 8-K 5.02,9.01 0001193125-26-203913 001-39655 26937307 34 183300 1 1
2026-05-01 ARS ARS 0001193125-26-201367 001-39655 26932287 34 2138190
2026-04-29 DEF 14A DEF 14A 0001193125-26-191429 001-39655 26915561 34 3958769 1 1
2026-04-29 DEFA14A DEFA14A 0001193125-26-191426 001-39655 26915552 34 338716 1 1
2026-04-23 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-174461 005-91812 26890214 34 7678
2026-04-23 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-174454 005-91812 26890212 34 7776
2026-04-20 8-K 8-K 4.01,9.01 0001193125-26-163909 001-39655 26874976 34 197283 1 1
2026-04-01 4 4 0001193125-26-138275 7787
2026-04-01 3 3 0001193125-26-138247 15429
2026-03-25 4 4 0001193125-26-124487 5739
2026-03-25 4 4 0001193125-26-124483 5726
2026-03-25 4 4 0001193125-26-124476 5679
2026-03-25 4 4 0001193125-26-124471 13644
2026-03-25 4 4 0001193125-26-124466 6354
2026-03-25 4 4 0001193125-26-124455 5656
2026-03-25 3 3 0001193125-26-124447 14132
2026-03-25 3 3 0001193125-26-124440 14420
2026-03-23 8-K 8-K 5.02,7.01,9.01 0001193125-26-118699 001-39655 26780065 34 521876 1 1
2026-03-20 S-8 S-8 0001193125-26-117594 333-294492 26778136 33 1164263 1 1
2026-03-19 10-K 10-K 0001193125-26-115922 001-39655 26774106 34 15966263 1 1
2026-03-10 8-K 8-K 2.02,5.03,7.01,9.01 0001193125-26-099404 001-39655 26737262 34 243776 1 1
2026-03-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-096746 005-91812 26731716 34 12193
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001738048-26-000036 005-91812 26644573 34 34874
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001154 005-91812 26642430 34 21528
2026-02-12 4 4 0001193125-26-047537 8142
2026-02-12 4 4 0001193125-26-047535 20049
2026-02-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-047007 005-91812 26622441 34 25925
2026-02-11 8-K 8-K 1.01,9.01 0001193125-26-046817 001-39655 26621931 34 500910 1 1
2026-02-11 424B5 424B5 0001193125-26-046779 333-293343 26621796 33 3219575 1 1
2026-02-10 424B5 424B5 0001193125-26-044766 333-293343 26616383 33 3141439
2026-02-10 S-3ASR S-3ASR 0001193125-26-044613 333-293343 26615802 33 3906251 1 1
2026-02-10 8-K 8-K 5.02,5.03,8.01,9.01 0001193125-26-043741 001-39655 26613498 34 290471 1 1
2026-01-26 4 4 0001193125-26-023094 7354
2026-01-26 3 3 0001193125-26-023089 14897
2026-01-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-010366 005-91812 26526755 34 8339
2026-01-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-010344 005-91812 26526669 34 8437
2026-01-12 8-K 8-K 7.01,9.01 0001193125-26-009812 001-39655 26524728 34 16261972 1 1
2026-01-07 4 4 0001193125-26-006723 7357
2026-01-07 3 3 0001193125-26-006720 15112
2026-01-06 4 4 0001193125-26-004573 8823
2026-01-06 4 4 0001193125-26-004568 8797
2026-01-06 4 4 0001193125-26-004565 8852
2026-01-06 8-K 8-K 3.02,5.02,9.01 0001193125-26-003490 001-39655 26509470 34 485148 1 1
2026-01-02 S-8 S-8 0001193125-26-001076 333-292564 26503167 33 418182 1 1
2025-12-31 DEF 14A DEF 14A 0001140361-25-047056 001-39655 251617653 34 7824288
2025-12-31 424B3 424B3 0001193125-25-338281 333-292175 251617435 33 2727164
2025-12-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003922 333-292175 251602306 33 1813
2025-12-22 CORRESP filename1.htm 0001193125-25-327461 8859
2025-12-16 PRE 14A PRE 14A 0001140361-25-045696 001-39655 251576357 34 7817721
2025-12-16 S-3 S-3 0001193125-25-321093 333-292175 251576194 33 3136303 1 1
2025-12-09 8-K/A 8-K/A 5.03,9.01 0001193125-25-312912 001-39655 251559825 34 207054 1 1
2025-12-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-309825 005-91812 251553594 34 202980
2025-12-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002950 005-91812 251552292 34 12576
2025-11-21 D xslFormDX01/primary_doc.xml 06b 0001193125-25-291332 021-564756 251507809 33 19897
2025-11-17 3 3 0001193125-25-285077 25873
2025-11-17 3 3 0001193125-25-285071 13769
2025-11-17 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-285070 005-91812 251492633 34 120835
2025-11-17 3 3 0001193125-25-285069 16505
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004918 005-91812 251479900 34 17951
2025-11-10 8-K 8-K 1.01,2.01,3.02,5.02,5.03,7.01,9.01 0001193125-25-273342 001-39655 251464509 34 11796097 1 1
2025-11-06 10-Q 10-Q 0001193125-25-269426 001-39655 251458022 34 6721595 1 1
2025-10-09 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001388325-25-000007 005-91812 251385401 34 8030
2025-09-25 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001388325-25-000004 005-91812 251344433 34 35965
2025-08-05 10-Q 10-Q 0000950170-25-102963 001-39655 251184701 34 6595768 1 1
2025-07-08 4 4 0000950170-25-094576 8881
2025-07-08 4 4 0000950170-25-094575 8869
2025-07-08 4 4 0000950170-25-094572 8795
2025-06-20 8-K 8-K 5.07 0000950170-25-088168 001-39655 251059049 34 220797 1 1
2025-06-20 4 4 0000950170-25-088167 5446
2025-06-20 4 4 0000950170-25-088166 5413
2025-06-20 4 4 0000950170-25-088165 5406
2025-06-20 4 4 0000950170-25-088164 5397
2025-06-20 4 4 0000950170-25-088163 5373
2025-06-20 4 4 0000950170-25-088162 5369
2025-05-08 10-Q 10-Q 0000950170-25-066884 001-39655 25925787 34 5806794 1 1
2025-04-30 ARS ARS 0000950170-25-061110 001-39655 25895896 34 4530605
2025-04-30 DEFA14A DEFA14A 0000950170-25-061001 001-39655 25894708 34 1606332
2025-04-30 DEF 14A DEF 14A 0000950170-25-060552 001-39655 25890852 34 2762618 1 1
2025-04-17 PRE 14A PRE 14A 0000950170-25-055354 001-39655 25847150 34 2735324 1 1
2025-03-19 S-8 S-8 0000950170-25-042051 333-285920 25753182 33 324740 1 1
2025-03-19 10-K 10-K 0000950170-25-041981 001-39655 25752609 34 17612506 1 1
2025-01-16 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-006448 005-91812 25536851 34 67108
2025-01-07 4 4 0000950170-25-002814 11220
2025-01-07 4 4 0000950170-25-002813 11144
2025-01-07 4 4 0000950170-25-002812 5429
2025-01-07 4 4 0000950170-25-002811 11233
2024-11-07 SC 13G/A SC 13G/A 0001193125-24-253039 005-91812 241434859 34 69870
2024-11-07 SC 13G SC 13G 0001193125-24-253029 005-91812 241434831 34 77362
2024-11-01 10-Q 10-Q 0000950170-24-119809 001-39655 241417105 34 6232036 1 1
2024-10-15 4 4 0000950170-24-114680 7650
2024-10-15 3 3 0000950170-24-114669 13772
2024-10-15 8-K 8-K 5.02,9.01 0000950170-24-114481 001-39655 241369634 34 195577 1 1
2024-10-11 4 4 0000950170-24-114386 5335
2024-10-11 4 4 0000950170-24-114385 5347
2024-10-11 4 4 0000950170-24-114387 5361
2024-10-11 4 4 0000950170-24-114384 5370
2024-10-11 3 3 0000950170-24-114347 15529
2024-10-07 8-K 8-K 1.01,2.01,3.02,5.02,5.03,7.01,9.01 0000950170-24-113091 001-39655 241356303 34 17810012 1 1
2024-09-18 8-K 8-K 8.01 0000950170-24-107580 001-39655 241306101 34 197787 1 1
2024-09-11 8-K 8-K 8.01 0000950170-24-105533 001-39655 241292992 34 197784 1 1
2024-09-05 8-K 8-K 5.03,9.01 0000950170-24-103957 001-39655 241281319 34 224815 1 1
2024-08-29 SC 13G/A glto13Agv3.htm 0001995601-24-000004 005-91812 241265153 34 30393
2024-08-16 3 3 0000950170-24-098036 19514
2024-08-12 10-Q 10-Q 0000950170-24-095383 001-39655 241196611 34 6010465 1 1
2024-06-24 SC 13D/A SC 13D/A 0001193125-24-167233 005-91812 241066006 34 63079
2024-06-21 8-K 8-K 5.07 0000950170-24-076186 001-39655 241060050 34 218438 1 1
2024-06-21 4 4 0000950170-24-076191 5412
2024-06-21 4 4 0000950170-24-076188 5424
2024-06-21 4 4 0000950170-24-076187 5377
2024-06-21 4 4 0000950170-24-076183 5417
2024-06-21 4 4 0000950170-24-076182 5457
2024-04-29 10-Q 10-Q 0000950170-24-049808 001-39655 24890433 34 5320303 1 1
2024-04-29 DEF 14A DEF 14A 0000950170-24-049811 001-39655 24890418 34 1837129
2024-04-16 PRE 14A PRE 14A 0000950170-24-044763 001-39655 24847746 34 1835227
2024-03-26 8-K 8-K 8.01 0000950170-24-036391 001-39655 24783416 34 177606 1 1
2024-03-08 S-8 S-8 0000950170-24-028663 333-277792 24734828 33 192093
2024-03-08 10-K 10-K 0000950170-24-028610 001-39655 24734190 34 9627082 1 1
2024-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001995601-24-000002 005-91812 24614271 34 6144
2024-01-05 4 4 0000950170-24-002433 5522
2024-01-05 4 4 0000950170-24-002429 5513
2024-01-05 4 4 0000950170-24-002430 5540
2023-12-21 8-K 8-K 8.01,9.01 0000950170-23-072258 001-39655 231505694 34 186135 1 1
2023-11-06 10-Q 10-Q 0000950170-23-059367 001-39655 231379868 34 6693460 1 1
2023-10-23 8-K 8-K 8.01,9.01 0000950170-23-054508 001-39655 231338674 34 234633 1 1
2023-10-03 SC 13G GALECTO13G 0001995601-23-000002 005-91812 231302103 34 30390
2023-10-02 144 xsl144X01/primary_doc.xml 0000947871-23-000972 001-39655 231301494 33 19692
2023-10-02 144 xsl144X01/primary_doc.xml 0000947871-23-000971 001-39655 231301492 33 20380
2023-10-02 144 xsl144X01/primary_doc.xml 0000947871-23-000970 001-39655 231301488 33 19885
2023-10-02 144 xsl144X01/primary_doc.xml 0000947871-23-000969 001-39655 231301486 33 19999
2023-10-02 8-K 8-K 3.01 0000950170-23-051118 001-39655 231299504 34 187885 1 1
2023-09-26 8-K 8-K 2.05,5.02,8.01,9.01 0000950170-23-049919 001-39655 231280497 34 243627 1 1
2023-09-18 SC 13D/A AMENDMENT NO. 6 0000947871-23-000940 005-91812 231261425 34 195504
2023-09-05 SC 13D/A AMENDMENT NO. 5 0000947871-23-000922 005-91812 231236026 34 217352
2023-08-30 144 xsl144X01/primary_doc.xml 0000947871-23-000912 001-39655 231226134 33 11866
2023-08-30 144 xsl144X01/primary_doc.xml 0000947871-23-000911 001-39655 231226051 33 12274
2023-08-30 144 xsl144X01/primary_doc.xml 0000947871-23-000910 001-39655 231225994 33 12000
2023-08-30 144 xsl144X01/primary_doc.xml 0000947871-23-000909 001-39655 231225918 33 12065
2023-08-21 144/A xsl144X01/primary_doc.xml 0000947871-23-000888 001-39655 231190737 33 7658
2023-08-21 144 xsl144X01/primary_doc.xml 0000947871-23-000887 001-39655 231189809 33 7459
2023-08-21 144 xsl144X01/primary_doc.xml 0000947871-23-000886 001-39655 231189791 33 6767
2023-08-21 144 xsl144X01/primary_doc.xml 0000947871-23-000884 001-39655 231189747 33 7323
2023-08-21 144 xsl144X01/primary_doc.xml 0000947871-23-000883 001-39655 231189668 33 7567
2023-08-17 4 xslF345X05/ownership.xml 0000947871-23-000873 18135
2023-08-17 SC 13D/A AMENDMENT NO. 4 0000947871-23-000872 005-91812 231182337 34 183181
2023-08-15 144 xsl144X01/primary_doc.xml 0000947871-23-000867 001-39655 231176061 33 6672
2023-08-15 144 xsl144X01/primary_doc.xml 0000947871-23-000866 001-39655 231176055 33 6892
2023-08-15 144 xsl144X01/primary_doc.xml 0000947871-23-000865 001-39655 231176047 33 6799
2023-08-15 144 xsl144X01/primary_doc.xml 0000947871-23-000864 001-39655 231176035 33 6767
2023-08-15 8-K 8-K 7.01,8.01,9.01 0000950170-23-042631 001-39655 231173253 34 262620 1 1
2023-08-02 4 xslF345X05/ownership.xml 0000947871-23-000809 18135
2023-08-02 SC 13D/A AMENDMENT NO. 3 0000947871-23-000808 005-91812 231136769 34 187156
2023-07-31 144 xsl144X01/primary_doc.xml 0000947871-23-000798 001-39655 231128944 33 6021
2023-07-31 144 xsl144X01/primary_doc.xml 0000947871-23-000797 001-39655 231128932 33 6219
2023-07-31 144 xsl144X01/primary_doc.xml 0000947871-23-000796 001-39655 231128920 33 6138
2023-07-31 144 xsl144X01/primary_doc.xml 0000947871-23-000795 001-39655 231128911 33 6114
2023-07-31 10-Q 10-Q 0000950170-23-035925 001-39655 231127339 34 6990015 1 1
2023-07-27 4 xslF345X05/ownership.xml 0000947871-23-000789 18682
2023-07-25 144 xsl144X01/primary_doc.xml 0000947871-23-000782 001-39655 231109344 33 5366
2023-07-25 144 xsl144X01/primary_doc.xml 0000947871-23-000781 001-39655 231109319 33 5542
2023-07-25 144 xsl144X01/primary_doc.xml 0000947871-23-000780 001-39655 231109297 33 5476
2023-07-25 144 xsl144X01/primary_doc.xml 0000947871-23-000779 001-39655 231109262 33 5454
2023-07-17 4 xslF345X05/ownership.xml 0000947871-23-000753 18135
2023-07-17 SC 13D/A AMENDMENT NO. 2 0000947871-23-000752 005-91812 231091729 34 183164
2023-07-13 144 xsl144X01/primary_doc.xml 0000947871-23-000751 001-39655 231087773 33 5692
2023-07-13 144 xsl144X01/primary_doc.xml 0000947871-23-000750 001-39655 231087769 33 5509
2023-07-13 144 xsl144X01/primary_doc.xml 0000947871-23-000749 001-39655 231087763 33 5629
2023-07-13 144 xsl144X01/primary_doc.xml 0000947871-23-000748 001-39655 231087757 33 5600
2023-06-15 8-K 8-K 5.07 0000950170-23-028265 001-39655 231017269 34 212510 1 1
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037288 5566
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037287 5558
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037286 5570
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037285 5526
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037284 5603
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037283 5574
2023-04-28 ARS ARS 0000950170-23-015500 001-39655 23860695 34 2895232
2023-04-28 DEFA14A DEFA14A 0000950170-23-015484 001-39655 23860214 34 336882
2023-04-28 DEF 14A DEF 14A 0000950170-23-015475 001-39655 23860092 34 1237258
2023-04-28 10-Q 10-Q 0000950170-23-015461 001-39655 23859814 34 6295438 1 1
2023-04-17 4 xslF345X04/ownership.xml 0000947871-23-000472 28183
2023-04-12 4 xslF345X04/ownership.xml 0000947871-23-000452 28183
2023-04-10 144 xsl144X01/primary_doc.xml 0000947871-23-000446 001-39655 23812261 33 5617
2023-04-10 144 xsl144X01/primary_doc.xml 0000947871-23-000445 001-39655 23812260 33 5537
2023-04-10 144 xsl144X01/primary_doc.xml 0000947871-23-000444 001-39655 23812255 33 5730
2023-04-10 144 xsl144X01/primary_doc.xml 0000947871-23-000443 001-39655 23812251 33 5657
2023-04-07 4 xslF345X04/ownership.xml 0000947871-23-000438 23130
2023-04-07 SC 13D/A AMENDMENT NO. 1 0000947871-23-000437 005-91812 23809068 34 187181
2023-04-05 144 xsl144X01/primary_doc.xml 0000947871-23-000427 001-39655 23803625 33 4918
2023-04-05 144 xsl144X01/primary_doc.xml 0000947871-23-000426 001-39655 23803612 33 4860
2023-04-05 144 xsl144X01/primary_doc.xml 0000947871-23-000425 001-39655 23803608 33 4759
2023-04-05 144 xsl144X01/primary_doc.xml 0000947871-23-000424 001-39655 23803600 33 4840
2023-03-10 8-K 8-K 7.01 0000950170-23-007228 001-39655 23723283 34 199556 1 1
2023-03-09 S-8 S-8 0000950170-23-006822 333-270380 23718114 33 458457
2023-03-09 424B5 424B5 0000950170-23-006820 333-260778 23718111 33 87258
2023-03-09 10-K 10-K 0000950170-23-006807 001-39655 23718062 34 11878689 1 1
2023-01-06 8-K 8-K 2.02,7.01,9.01 0000950170-23-000283 001-39655 23513735 34 23062909 1 1
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001760 5580
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001757 5560
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001759 5578
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001756 5597
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001758 5567
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001755 5576
2022-11-08 10-Q 10-Q 0000950170-22-022935 001-39655 221367429 34 7138779 1 1
2022-10-31 8-K 8-K 7.01,9.01 0000950170-22-020535 001-39655 221343917 34 281700 1 1
2022-09-30 SC 13D/A SC 13D/A 0001193125-22-255659 005-91812 221284718 34 65134
2022-09-29 8-K 8-K 7.01,8.01,9.01 0000950170-22-018988 001-39655 221277682 34 273909 1 1
2022-07-29 10-Q 10-Q 0000950170-22-013434 001-39655 221117276 34 6932314 1 1
2022-06-17 8-K 8-K 5.07 0000950170-22-011770 001-39655 221022377 34 205090 1 1
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036936 5537
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036935 5533
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036934 5525
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036933 5550
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036932 5493
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036931 5570
2022-04-29 10-Q 10-Q 0000950170-22-006612 001-39655 22870059 34 5894385 1 1
2022-04-28 DEFA14A DEFA14A 0000950170-22-006558 001-39655 22867301 34 300969
2022-04-28 DEF 14A DEF 14A 0000950170-22-006557 001-39655 22867180 34 1286390
2022-03-23 4 FORM 4 SUBMISSION 0001209191-22-020683 4594
2022-03-23 4 FORM 4 SUBMISSION 0001209191-22-020682 4597
2022-02-18 424B5 424B5 0001564590-22-005716 333-260778 22653682 33 76883
2022-02-17 S-8 S-8 0001564590-22-005574 333-262823 22648722 33 127063
2022-02-17 10-K 10-K 0001564590-22-005569 001-39655 22648503 34 13569752 1 1
2022-02-15 4 FORM 4 SUBMISSION 0001209191-22-009735 5563
2022-02-14 SC 13G/A schedule13g.htm 0000929638-22-000489 005-91812 22630293 34 130822
2022-02-11 SC 13G/A SCHEDULE 13G/A 0001104659-22-020446 005-91812 22620595 34 35561
2022-02-10 SC 13G/A SC 13G/A 0001193125-22-034616 005-91812 22615084 34 153041
2022-02-10 SC 13G/A JANUS HENDERSON GROUP PLC OWNS <5% 0001274173-22-000006 005-91812 22612130 34 10198
2022-02-09 8-K 8-K 5.02,9.01 0001564590-22-004414 001-39655 22607654 34 228956 1 1
2022-01-27 8-K 8-K 8.01,9.01 0001564590-22-002577 001-39655 22559992 34 220446 1 1
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002215 5580
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002214 5576
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002212 5578
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002213 5567
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002211 5597
2022-01-05 3 FORM 3 SUBMISSION 0001209191-22-001763 7679
2022-01-05 8-K 8-K 7.01,9.01 0001564590-22-000413 001-39655 22511048 34 8736828 1 1
2021-12-06 4 FORM 4 SUBMISSION 0001209191-21-068028 4587
2021-12-06 4 FORM 4 SUBMISSION 0001209191-21-068027 4599
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065847 5574
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065841 5536
2021-11-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-11-12 16:01:00 9999999995-21-004331 333-260778 211405917 33 1771
2021-11-10 CORRESP filename1.htm 0001564590-21-056165 16349
2021-11-10 UPLOAD filename1.pdf 0000000000-21-013636 40208
2021-11-10 4 FORM 4 SUBMISSION 0001209191-21-063798 4598
2021-11-09 4 FORM 4 SUBMISSION 0001209191-21-063523 4598
2021-11-04 S-3 S-3 0001564590-21-054556 333-260778 211380937 33 2454749
2021-11-04 10-Q 10-Q 0001564590-21-054462 001-39655 211379788 34 6937626 1 1
2021-08-19 4 FORM 4 SUBMISSION 0001209191-21-052512 4598
2021-08-05 10-Q 10-Q 0001564590-21-041147 001-39655 211146145 34 6481156 1 1
2021-07-06 8-K 8-K 5.02,9.01 0001564590-21-035806 001-39655 211072624 34 198827
2021-06-28 4 FORM 4 SUBMISSION 0001209191-21-043464 4593
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-042986 4598
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042719 4598
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042718 4587
2021-06-16 4 FORM 4 SUBMISSION 0001209191-21-040944 5575
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036508 5568
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036510 5523
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036509 6114
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036507 5491
2021-05-28 8-K 8-K 5.07 0001564590-21-030604 001-39655 21976463 34 53413
2021-05-11 3 FORM 3 SUBMISSION 0001209191-21-031474 3036
2021-05-04 10-Q 10-Q 0001564590-21-022987 001-39655 21885980 34 4864376 1
2021-04-14 DEFA14A DEFA14A 0001564590-21-018764 001-39655 21824514 34 409042
2021-04-14 DEF 14A DEF 14A 0001564590-21-018763 001-39655 21824508 34 1124841
2021-03-29 S-8 S-8 0001564590-21-015967 333-254805 21779533 33 111594
2021-03-29 10-K 10-K 0001564590-21-015916 001-39655 21779341 34 11383247 1
2021-03-15 8-K 8-K 7.01,9.01 0001564590-21-013008 001-39655 21739851 34 79470
2021-02-16 SC 13G/A schedule13g.htm 0000929638-21-000378 005-91812 21637168 34 131041
2021-02-12 SC 13G/A SC 13G/A 0001193125-21-041869 005-91812 21629433 34 160837
2021-02-12 SC 13G SC 13G 0001104659-21-021872 005-91812 21626963 34 50427
2021-02-12 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-21-000081 005-91812 21626440 34 7810
2021-01-08 4 FORM 4 SUBMISSION 0001209191-21-002693 8014
2021-01-08 3 FORM 3 SUBMISSION 0001209191-21-002691 7656
2021-01-08 8-K 8-K 5.02,9.01 0001564590-21-000619 001-39655 21515699 34 64252
2021-01-07 4 FORM 4 SUBMISSION 0001209191-21-002476 10293
2021-01-07 4 FORM 4 SUBMISSION 0001209191-21-002477 10365
2021-01-07 4 FORM 4 SUBMISSION 0001209191-21-002474 10309
2021-01-07 4 FORM 4 SUBMISSION 0001209191-21-002475 10290
2021-01-05 8-K 8-K 2.02,7.01,9.01 0001564590-21-000275 001-39655 21506072 34 3494213
2020-12-11 10-Q 10-Q 0001564590-20-056793 001-39655 201382246 34 5838069 1
2020-11-23 4 FORM 4 SUBMISSION 0000899243-20-031922 8108
2020-11-23 3 FORM 3 SUBMISSION 0000899243-20-031911 7895
2020-11-23 8-K 8-K 5.02,9.01 0001193125-20-301174 001-39655 201337385 34 53330
2020-11-12 SC 13G schedule13g.htm 0000929638-20-001088 005-91812 201307065 34 137473
2020-11-12 SC 13G formsch13g.htm 0001493152-20-021030 005-91812 201303812 34 358292
2020-11-06 SC 13D SCHEDULE 13D 0000947871-20-000855 005-91812 201295285 34 191200
2020-11-05 SC 13D SC 13D 0001193125-20-286884 005-91812 201291100 34 108335
2020-11-05 D xslFormDX01/primary_doc.xml 06b 0001800315-20-000003 021-379762 201288089 33 14354
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030416 18812
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030415 13279
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030414 51180
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030413 12711
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030412 13287
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030411 42947
2020-11-04 4 FORM 4 SUBMISSION 0000899243-20-030410 9887
2020-11-04 4 FORM 4 SUBMISSION 0001209191-20-057030 27153
2020-11-04 8-K 8-K 5.03,9.01 0001193125-20-285653 001-39655 201287392 34 150468
2020-11-04 S-8 S-8 0001193125-20-285647 333-249852 201287375 33 74326
2020-10-30 424B4 424B4 0001193125-20-282633 333-249369 201277760 33 4640678
2020-10-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-10-28 16:00:00 9999999995-20-003010 333-249369 201270292 33 1712
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029589 24194
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029588 21293
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029583 7733
2020-10-28 3 FORM 3 SUBMISSION 0001209191-20-056160 13299
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029581 12446
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029580 14925
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029577 9189
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029576 9938
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029574 9115
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029572 16478
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029571 10434
2020-10-28 3 FORM 3 SUBMISSION 0000899243-20-029569 10517
2020-10-28 CERT 8A CERT 0001354457-20-000646 001-39655 201266462 34 487962
2020-10-26 CORRESP filename1.htm 0001193125-20-277052 25327
2020-10-23 8-A12B FORM 8-A12B 0001193125-20-275442 001-39655 201257813 34 14858
2020-10-23 CORRESP filename1.htm 0001193125-20-275431 9734
2020-10-23 CORRESP filename1.htm 0001193125-20-275421 8178
2020-10-22 S-1/A S-1/A 0001193125-20-273986 333-249369 201251599 33 6295058
2020-10-20 CORRESP filename1.htm 0001193125-20-273119 71829
2020-10-19 UPLOAD filename1.pdf 0000000000-20-009871 44844
2020-10-13 CORRESP filename1.htm 0001193125-20-268782 56817
2020-10-07 CORRESP filename1.htm 0001193125-20-265632 74775
2020-10-07 S-1 FORM S-1 0001193125-20-265628 333-249369 201229585 33 5493977
2020-09-29 UPLOAD filename1.pdf 0000000000-20-009159 53964
2020-09-02 DRS filename1.htm 0000950123-20-009492 377-03490 201157447 33 4183709
2020-01-16 D xslFormDX01/primary_doc.xml 06b 0001800315-20-000001 021-358296 20531489 33 6638

Latest XBRL company facts

One latest value per concept from companyfacts (231 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 61.90M 2026-11-02 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
dei EntityPublicFloat Entity Public Float USD 4.40M 2025-06-30 2025 FY 10-K 2026-03-19 0001193125-26-115922
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 976,736 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191429
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 708,983 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191429
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.13M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191429
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.30M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191429
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 127.83 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191429
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.08M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 293,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 12.83M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 12.83M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 72,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -233,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 944.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 16.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 28.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap Assets Assets USD 532.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AssetsCurrent Assets, Current USD 531.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 205.08M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 974,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 179.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 25.51M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 25.49M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 35.99M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 35.99M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 178.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 35.99M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 25.49M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 349.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 349.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 92.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 19.70M 2024-09-30 2024 Q3 10-Q 2024-11-01 0000950170-24-119809
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006807
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 61.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 61.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -91.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 89.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions pure 18 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 89.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions pure 18 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 178.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions pure 36 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 15,000 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028610
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 676,000 2020-09-30 2020 Q3 10-Q 2020-12-11 0001564590-20-056793
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 75.43M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 809,000 2020-12-31 2021 FY 10-K 2022-02-17 0001564590-22-005569
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 63.20M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 4,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.19M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 914,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 70,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 75.43M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap Depreciation Depreciation USD 16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap DividendIncomeOperating Dividend Income, Operating USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.34 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-07-29 0000950170-22-013434
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.175 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-015916
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.023 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-17 0001564590-22-005569
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 750,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap GainLossOnSaleOfProperty Gain (Loss) on Disposition of Oil and Gas and Timber Property USD 64,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 64,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 27.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -205.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -90.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -3.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncomeTaxesReceivableNoncurrent Income Taxes Receivable, Noncurrent USD 856,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 297,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 4.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -44.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 36.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 10.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -30,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 856,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 461,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 11.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap InvestmentsAndCash Investments and Cash USD 257.60M 2025-12-31 2026 Q2 10-Q 2026-08-10 0001193125-26-342307
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 360,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 17,000 2024-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 19,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 458,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 466,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 5,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269426
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 185,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap Liabilities Liabilities USD 36.87M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 532.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LiabilitiesCurrent Liabilities, Current USD 35.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 11.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap LongTermInvestments Long-term Investments USD 25.49M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap MarketableSecurities Marketable Securities USD 0 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 178.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD -70,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028610
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 5.83M 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028610
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -70,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028610
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -974,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 200.60M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 330.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -178.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -59.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -90.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -38.34M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 12.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingExpenses Operating Expenses USD 102.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -102.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseCost Operating Lease, Cost USD 32,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 153,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 946,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeasePayments Operating Lease, Payments USD 15,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 830,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 327,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OptionContractIndexedToEquitySettlementShareFairValue OptionContractIndexedToEquitySettlementShareFairValue USD 11.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 574,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 480,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD -70,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028610
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -974,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 28,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 469,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 21.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.70M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 25.94M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 17.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 179.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 196,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028610
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 0.001 2024-06-30 8-K 2024-10-07 0000950170-24-113091
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 7.65M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-09-30 2024 Q3 10-Q 2024-11-01 0000950170-24-119809
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-09-30 2024 Q3 10-Q 2024-11-01 0000950170-24-119809
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-09-30 2024 Q3 10-Q 2024-11-01 0000950170-24-119809
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap PrepaidInsurance Prepaid Insurance USD 70,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 351.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.88M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 39.67M 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041147
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 266.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 703,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 11.65M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 750,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 83,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-17 0001564590-22-005569
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -90.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 0 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-17 0001564590-22-005569
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 108,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 36,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 74.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 16.79M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-29 0001564590-21-015916
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 0 2021-12-31 2021 FY 10-K 2022-02-17 0001564590-22-005569
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 197,000 2021-03-31 2022 Q1 10-Q 2022-04-29 0000950170-22-006612
us-gaap RestructuringCharges Restructuring Charges USD 968,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap RestructuringCosts Restructuring Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap RestructuringReserve Restructuring Reserve USD 0 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 121,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-19 0000950170-25-041981
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -578.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.838 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.17M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.27M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.97 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 138,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 18.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 6.21M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 24.23 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 6.02M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 21 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 6.21M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 24.23 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.47 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 93.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 25.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ShortTermInvestments Short-term Investments USD 35.99M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054462
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 495.76M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.04 2024-08-29 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 94,202 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 295.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 38,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 703,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap TenantImprovements Tenant Improvements USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 8.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115922
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 24,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 52.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 25.27M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-07-29 0000950170-22-013434
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 52.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447162

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →